期刊文献+

YKL-40在良恶性胸腔积液鉴别诊断中的价值

下载PDF
导出
摘要 目的 探讨YKL-40在良恶性胸腔积液中的鉴别诊断价值。方法 选取胸腔积液患者95例,其中恶性胸腔积液(MPE)42例,良性胸腔积液(BPE)53例。采用夹心酶联免疫吸附法检测胸腔积液及血浆中YKL-40浓度。结果 MPE中YKL-40显著高于BPE中(P〈0.05)。然而,胸腔积液中YKL-40和癌胚抗原(CEA)间无相关性(r=0.2478,P=0.298)。YKL-40在诊断MPE的最佳临界值为180.2 ng/ml,受试者工作特征曲线下面积为0.7944(95%0.68-0.89,P〈0.01),其敏感度为83.9%,特异度为73.3%,具有较高的诊断价值。结论 检测胸腔积液中YKL-40有助于MPE的鉴别诊断。
出处 《现代实用医学》 2016年第8期1067-1069,共3页 Modern Practical Medicine
基金 宁波市自然科学基金项目(2016A610193)
  • 相关文献

参考文献9

  • 1Light RW. Update on tuberculous pleuralefiusion[J]. Respirology,2010,15(3):451-458.
  • 2Volck B, Johansen JS, Stoltenberg M, etal. Studies on YKL-40 in knee joints o f patientswith rheumatoid arthritis and osteoarthritis.Involvement o f YKL-40 in the joint pathology[J]. Osteoarthritis Cartilage,2001,9(3):203-214.
  • 3Choi IK, Kim YH, Kim JS, et al. High serumYKL-40 is a poor prognostic marker inpatients with advanced non-small cell lungcancer[J]. Acta Oncol,2010,49(6):861- 864.
  • 4Thom I, Andritzky B, Schuch G, et al. Elevatedpretreatment serum concentration ofYKL-40-An independent prognostic biomarker forsurvival in patients with metastatic noncelllung cancer[J]. Cancetr,2010,116(17):4114-4121.
  • 5Roslind A, Johansen JS, Christensen IJ, etal. High serum levels o f YKL-40 in patientswith squamous cell carcinoma of the headand neck are associated with short survival[J].Int J Cancer,2008,122(4): 857-863.
  • 6Hooper C, Lee YC, Maskell N. Investigationo f a unilateral pleural effusion in adults:British Thoracic Society Pleural DiseaseGuideline 2010[J]. Thorax,2010, 65(Suppl2): i4-il7.
  • 7黄鑫炎,谢灿茂.胸腔积液的诊断进展——诊断思路[J].内科急危重症杂志,2012,18(3):129-133. 被引量:15
  • 8Attia A, Rasmy A, Amin A, et al. Evaluationo f pleural fluid YKL-40 as a markero f malignant pleural effusion[J]. EgyptianJournal of Chest Diseases and Tuberculosis,2015,64(2):489-495.
  • 9Shao R, Hamel K, Petersen L, et al. YKL-40,a secreted glycoprotein, promotes tumorangiogenesis [J]. Oncogene, 2009,28 (50):4456-4468.

二级参考文献39

  • 1Heffner JE,Brown LK,Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions[J].Chest,1997,(04):970-980.
  • 2Romero-Candiera S,Hernández L,Romero-Brufao S. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions[J].Chest,2002,(05):1524-1529.doi:10.1378/chest.122.5.1524.
  • 3Romero-Candiera S,Fernánde z C,Martin C. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure[J].American Journal of Medicine,2001,(09):681-686.
  • 4Gotsman I,Fridlender Z,Mcirovitz A. The evaluation of pleural effusions in patients with heart failure[J].American Journal of Medicine,2001,(05):375-378.
  • 5Porcel JM,Martínez-Alonso M,Cao G. Biomarkers of heart failure in pleural fluid[J].Chest,2009,(03):671-677.
  • 6Porcel JM,Chorda J,Cao G. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light 's criteria[J].Respirology,2007,(05):654-659.doi:10.1111/j.1440-1843.2007.01109.x.
  • 7Heffner JE. Diagnosis and management of malignant pleural effusions[J].Respirology,2008,(01):5-20.
  • 8Maskell NA,Davies CW,Nunn A J. U.K.Controlled trial of intrapleural streptokinase for pleural infection[J].New England Journal of Medicine,2005,(09):865-874.
  • 9Barnes TW,Olson EJ,Morgenthaler TI. Low yield of micro-biologic studies on pleural fluid specimens[J].Chest,2005,(03):916-921.
  • 10Utine GE,Pinar A,Ozξelik U. Pleural fluid PCR method for detection of Staphylococcus aureus,Streptococcus pneumoniae and Haemophilus influenzae in pediatric parapneumonic effusions[J].Respiration;International Review of Thoracic Diseases,2008,(04):437-442.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部